Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Prolonged Share Price Weakness

Recent share performance puts DSM-Firmenich in focus

DSM-Firmenich (ENXTAM:DSFIR) has come onto investors’ radar after a series of weak returns, including an 18% decline over the past 3 months and a 41% negative total return over the past year.

See our latest analysis for DSM-Firmenich.

The recent weakness has been fairly persistent, with a 1-day share price return of a 1.91% decline and a 30-day share price return of a 17.06% decline adding to a 1-year total shareholder return of a 40.69% decline from the current €55.42 level. This points to fading momentum as the market reassesses DSM-Firmenich’s risk and growth profile.

If DSM-Firmenich’s recent slide has you reassessing your options, it could be a moment to broaden your search with our screener of 99 top founder-led companies and see what else stands out.

With the share price under pressure yet trading at a discount to some valuation estimates, the key question for you is whether DSM-Firmenich is currently undervalued or whether the market is already incorporating its future growth into the price.

Most Popular Narrative: 33.5% Undervalued

DSM-Firmenich’s most followed valuation story points to a fair value of €83.30 versus the current €55.42, framing the recent share price slump in a very different light.

The successful integration of legacy DSM and Firmenich is delivering targeted cost and revenue synergies (€200 million plus €200 million vitamin transformation), with synergies continuing to flow through in coming quarters, providing further support to both revenue and EBITDA margin improvement.

Read the complete narrative.

Want to see what is really driving that higher fair value? The narrative leans heavily on stronger earnings power, firmer margins, and a richer future profit multiple. The exact mix of these inputs might surprise you.

Result: Fair Value of €83.30 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story could unravel if softer global account demand persists or if currency swings continue to weigh on reported earnings and cash flow.

Find out about the key risks to this DSM-Firmenich narrative.

Another angle on valuation

While the narrative suggests DSM-Firmenich is 33.5% undervalued at a fair value of €83.30, our DCF model presents a different perspective, with future cash flows indicating a value of €113.03 per share. With the market at €55.42, which view do you find more convincing?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

The mix of weak recent returns and upbeat valuation stories can feel confusing, so act while the details are fresh and shape your own view by checking the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If this story has sparked fresh thinking, do not stop here; broaden your watchlist now so you are not looking back at missed chances later.

• Target more resilient cash flows by scanning our 463 dividend fortresses for income ideas that aim to balance yield with business strength.
• Spot potential value opportunities early by checking the 223 high quality undervalued stocks that currently pass our quality and pricing filters.
• Uncover lesser-known names with solid fundamentals through our screener containing 581 high quality undiscovered gems before they show up on everyone else’s radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com